Voluntary Benefits

The manufacturer recently said one version of the drug could cost $346 per month.

The appearance of the bill now raises questions about whether a major health legislation package is forming.

AM best changed its outlook for U.S. health insurers to neutral, from positive, in August, and it announced recently that its outlook for the industry is till negative.

Support for use of AI in providing health care is much lower.

Part-time and self-employed workers are significantly more likely to be searching for better benefits.

Senate Democrats are preparing a bill for quick floor action, and benefits groups are hoping for a boost for ICHRAs and association health plans.